Physician
Pathology
Dr. Elizabeth M. Azzato, MD
|
|
Give Review
Elizabeth Azzato is an expert in the field of Pathology. He attended Duke University School of Medicine. Duke University School of Medicine is one of the top medical schools in the US. Duke University School of Medicine has a rank of 8 in research and a 29 in primary care Elizabeth Azzato is also a published MD. He has 16 paper published. The most recent paper is: Development and implementation of a custom integrated database with dashboards to assist with hematopathology specimen triage and traffic.
Publications
- Genome-wide meta-analysis identifies regions on 7p21 (AHR) and 15q24 (CYP1A2) as determinants of habitual caffeine consumption.
- A genome-wide association study of prognosis in breast cancer.
- Maternal EPHX1 polymorphisms and risk of phenytoin-induced congenital malformations.
- Common germline polymorphisms in COMT, CYP19A1, ESR1, PGR, SULT1E1 and STS and survival after a diagnosis of breast cancer.
- Common germline variation in mismatch repair genes and survival after a diagnosis of colorectal cancer.
- Common single-nucleotide polymorphisms in DNA double-strand break repair genes and breast cancer risk.
- Development and implementation of a custom integrated database with dashboards to assist with hematopathology specimen triage and traffic.
- Monoclonal B cell lymphocytosis: clinical and population perspectives.
- Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival.
- PREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancer.
- SLC6A3 and body mass index in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
- Effects of common germline genetic variation in cell cycle control genes on breast cancer survival: results from a population-based cohort.
- Prevalent cases in observational studies of cancer survival: do they bias hazard ratio estimates?
- Common germ-line polymorphism of C1QA and breast cancer survival.
- A population-based validation of the prognostic model PREDICT for early breast cancer.
Schools
Duke University
Doctors Specialties
- Molecular Genetic Pathology
- Pathology
Accepted Insurances
Education
-
University of Pennsylvania Health System -
Duke University School of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Jeffrey M. Barroso, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Celia E. Manstein, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nimidia L. Oviedo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carrie M. Schneider, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mary B. Maher, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lea L. Gordon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Craig R. Soderquist, MD |
|
|
Dr. Matthew C. Hiemenz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vivianna M. Van Deerlin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John D. Alvarez, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jun S. Hou, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert B. Wilson, MD
This Doctor is OpenDoctor Recommended.
|